This company has been marked as potentially delisted and may not be actively trading. Organovo (ONVO) News Today Add Compare Share Share Headlines Stock AnalysisEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock ONVO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Driven! The Onvo L60 Is China’s Best Tesla Model Y Killer to DateMay 18, 2025 | msn.comTwo new option listings and one option delisting on April 24thApril 25, 2025 | markets.businessinsider.comVivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ MarketApril 24, 2025 | globenewswire.comOrganovo announces VivoSim to carry forward 3D bioprinting, legacy techApril 23, 2025 | markets.businessinsider.comOrganovo Holdings, Inc. Announces Name Change to VivoSim Labs, Inc. and New Ticker Symbol "VIVS"April 23, 2025 | quiverquant.comQVivoSim to Carry Forward Organovo 3D BioprintingApril 23, 2025 | globenewswire.comOrganovo expects to meet requirements for continued listing on NasdaqApril 2, 2025 | markets.businessinsider.comOrganovo Holdings Expects to Meet Nasdaq Listing RequirementsApril 2, 2025 | tipranks.comOrganovo Provides Update on Cash and Nasdaq Continued Listing RequirementsApril 2, 2025 | financialpost.comFOrganovo Provides Update on Cash and Nasdaq Continued Listing RequirementsApril 2, 2025 | globenewswire.comOrganovo sees cash runway through the end of FY26March 28, 2025 | markets.businessinsider.comOrganovo, Inc.: Organovo Provides Business UpdateMarch 27, 2025 | finanznachrichten.deOrganovo Provides Business UpdateMarch 27, 2025 | financialpost.comFOrganovo Provides Business UpdateMarch 27, 2025 | globenewswire.comOrganovo, Inc.: Organovo Announces Close of the Sale of FXR Program to Eli Lilly and CompanyMarch 26, 2025 | finanznachrichten.deOrganovo closes sale of FXR program to Eli LillyMarch 25, 2025 | markets.businessinsider.comOrganovo Announces Close of the Sale of FXR Program to Eli Lilly and CompanyMarch 25, 2025 | globenewswire.comOrganovo Announces 1-for-12 Reverse Stock Split To Maintain Nasdaq ComplianceMarch 21, 2025 | nasdaq.comOrganovo trading halted, news pendingMarch 20, 2025 | msn.comOrganovo, Inc.: Organovo Announces Reverse Stock SplitMarch 20, 2025 | finanznachrichten.deEquity Markets Rise After Fed Keeps Rates UnchangedMarch 19, 2025 | msn.comOrganovo Announces Reverse Stock SplitMarch 19, 2025 | globenewswire.comMatinas BioPharma Appoints Keith Murphy and Edward Neugeboren to Board of DirectorsMarch 11, 2025 | quiverquant.comQOrganovo Announces the Issuance of Additional Shares in Conjunction with Warrant ExercisesMarch 6, 2025 | globenewswire.comEli Lilly Plans 4 New US Manufacturing Sites With $27 Billion InvestmentFebruary 26, 2025 | msn.comEli Lilly pays $10m upfront for Organovo’s FXR agonistFebruary 26, 2025 | finance.yahoo.comOrganovo, Inc.: Organovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and CompanyFebruary 26, 2025 | finanznachrichten.deEli Lilly Expands Zepbound Vial Dose Options, Cuts Weight-Loss Drug's Prices for Self-Pay PatientsFebruary 26, 2025 | msn.comM&A News: Eli Lilly (LLY) Expands IBD Pipeline with Organovo’s FXR ProgramFebruary 26, 2025 | markets.businessinsider.comOrganovo’s FXR program to be acquired by Eli LillyFebruary 25, 2025 | markets.businessinsider.comWhy Organovo (ONVO) Stock Is SkyrocketingFebruary 25, 2025 | benzinga.comOrganovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and CompanyFebruary 25, 2025 | globenewswire.comARMISTICE CAPITAL, LLC Increases Stake in Organovo Holdings IncFebruary 15, 2025 | gurufocus.comOrganovo Holdings Delays Quarterly Report FilingFebruary 14, 2025 | tipranks.comOrganovo Appoints Norman Staskey As CFOJanuary 7, 2025 | markets.businessinsider.comOrganovo, Inc.: Organovo Announces Appointment of Norman Staskey as Chief Financial OfficerJanuary 6, 2025 | finanznachrichten.deOrganovo Announces Appointment of Norman Staskey as Chief Financial OfficerJanuary 6, 2025 | globenewswire.comOrganovo Holdings Appoints Norman Staskey as New CFODecember 31, 2024 | tipranks.comThe Tesla Model Y Is King. China's $21,000 Answer To It May Be BetterDecember 14, 2024 | msn.comOrganovo Holdings IncNovember 26, 2024 | money.usnews.comOrganovo Holdings Gains Approval for Key Strategic MovesNovember 23, 2024 | markets.businessinsider.comOrganovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver MeetingNovember 20, 2024 | globenewswire.comOrganovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver DiseasesNovember 13, 2024 | globenewswire.comONVO Releases Encouraging Quarterly ResultsNovember 12, 2024 | msn.comOrganovo files to sell common stock, warrants, no amount givenOctober 26, 2024 | markets.businessinsider.comOrganovo Holdings (NASDAQ:ONVO) Stock Quotes, Forecast and News SummaryOctober 13, 2024 | benzinga.comNio stock poised for 42% gain on ONVO sales momentumSeptember 28, 2024 | msn.comTesla Faces New Competition in China as Nio Launches Low-Cost SUVSeptember 21, 2024 | msn.comNio Drops Onvo L60 Price To Obliterate Tesla’s Model Y, Starts At $21KSeptember 21, 2024 | msn.comONVO Aug 2024 2.500 call (ONVO240816C00002500)August 13, 2024 | finance.yahoo.com Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address ONVO Media Mentions By Week ONVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONVO News Sentiment▼0.000.66▲Average Medical News Sentiment ONVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONVO Articles This Week▼01▲ONVO Articles Average Week Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NextCure News Today TherapeuticsMD News Today Bullfrog AI News Today Cyclacel Pharmaceuticals News Today Gelteq News Today Calidi Biotherapeutics News Today AlloVir News Today iBio News Today Carisma Therapeutics News Today Ernexa Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONVO) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organovo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organovo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access